newsfilter
← Latest News
Business Wire·

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Evaluation of Strategic Alternatives is Ongoing MEI Pharma, Inc. (NASDAQ:MEIP) (the "Company") today reported results for its quarter ended December 31, 2024. As previously announced in July 2024, the Company is